ADMA ADMA Biologics Inc - Common Stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 5, 2026
$9.72
· % 处于52周区间
· 高于低点
· 至高点
$7.2152周低点
$20.4652周高点
市值 (MRQ)
$2.19B
P/E (TTM)
13.9
EPS (TTM)
$0.70
收入 (TTM)
$512M
ADMA 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$9.72
市值 (MRQ)
$2.19B
P/E (TTM)
13.9
EPS (TTM)
$0.70
收入 (TTM)
$512M
ROE (TTM)
41.9%
负债/权益 (MRQ)
0.5
52周区间
$7–$20
ADMA 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
关于 ADMA Biologics Inc - Common Stock 公司概况（来自维基百科）
行业板块Healthcare
行业Biotechnology
员工640
国家US
10年表现 收入、净利润、利润率和每股收益趋势
收入$510M2023-12-31 → 2025-12-31
EPS$0.602023-12-31 → 2025-12-31
自由现金流$28M2023-12-31 → 2025-12-31
净利率33.0%2023-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | ADMA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | 13.9 | · | · | · | |
| P/S (TTM) | 4.3 | · | 29.2 | 低估 | |
| 市净率 (MRQ) | 5.4 | · | 5.4 | 公允价值 | |
| EV / EBITDA (企业价值 / EBITDA) | 11.5 | · | · | · | |
| 股价/自由现金流 (TTM) | 18.8 | · | · | · | |
| 市现率 (TTM) | 16.0 | · | · | · | |
| EV / Revenue (市值/营收) | 4.5 | · | · | · | |
| EV / FCF (市值/自由现金流) | 82.6 | · | · | · | |
| 市净率（有形资产） (MRQ) | 5.4 | · | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | ADMA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 毛利率 (TTM) | 64.7% | · | · | · | |
| 营业利润率 (TTM) | 43.8% | · | -1089.3% | 顶尖 | |
| 息税折旧摊销前利润率 (TTM) | 45.3% | · | -1089.3% | 顶尖 | |
| 税前利润率 (TTM) | 42.3% | · | -553.3% | 顶尖 | |
| 净利润率 (TTM) | 33.0% | · | -1113.0% | 顶尖 | |
| ROA (TTM) | 27.2% | · | -42.4% | 顶尖 | |
| ROE (TTM) | 41.9% | · | -59.4% | 顶尖 | |
| ROIC | 28.0% | · | -88.3% | 顶尖 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | ADMA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 负债/股东权益比率 (MRQ) | 0.5 | · | 0.0 | 高负债 | |
| 流动比率 (MRQ) | 7.0 | · | 8.5 | 低于平均水平 | |
| Quick Ratio (速动比率) | 3.5 | · | 5.9 | 低流动性 | |
| 长期负债/股东权益 (MRQ) | 0.5 | · | 0.2 | 高负债 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | ADMA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 19.6% | · | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 49.0% | · | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 64.6% | · | · | · | |
| EPS YoY | -25.9% | · | · | · | |
| Net Income YoY (净利润同比增长) | -25.7% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | ADMA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.9 | · | 0.1 | 顶尖 | |
| Inventory Turnover (库存周转率) | 1.2 | · | · | · | |
| Receivables Turnover (应收账款周转率) | 4.9 | · | 7.2 | 弱 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$797.1K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-7.5%
下次报告
十一月 03, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 12, 2026 | $0.16 | $0.18 | -9.1% |
| 2026年3月31日 | 五月 13, 2026 | $0.19 | $0.20 | -6.9% |
| 2025年12月31日 | $0.20 | $0.19 | 6.0% | |
| 2025年9月30日 | $0.15 | $0.15 | -2.0% | |
| 2025年6月30日 | $0.14 | $0.14 | -2.0% | |
| 2025年3月31日 | $0.11 | $0.16 | -31.2% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $510M | $426M | $258M | $154M | $81M | $42M | $29M | $17M | $23M | $11M | $7M | $6M | |
| Cost of Revenue | $217M | $207M | $169M | $119M | $80M | $61M | $40M | $42M | $29M | $2M | $4M | $4M | |
| Gross Profit | $293M | $220M | $89M | $35M | $1M | $-19M | · | $-25M | $-6M | $4M | $3M | $2M | |
| R&D Expense | $5M | $2M | $3M | $4M | $4M | $6M | $2M | $4M | $6M | $8M | $7M | $10M | |
| SG&A Expense | $92M | $74M | $59M | $52M | $43M | $35M | $26M | $23M | $19M | $8M | $7M | $5M | |
| Operating Expenses | $101M | $81M | $67M | $75M | $60M | $46M | $71M | $77M | $62M | $28M | $23M | $22M | |
| Operating Income | $191M | $139M | $22M | $-39M | $-58M | $-65M | $-41M | $-60M | $-39M | $-17M | $-16M | $-16M | |
| Interest Expense | · | · | $25M | $19M | $13M | $12M | $9M | $6M | $3M | $2M | $2M | $1M | |
| Interest Income | $2M | $2M | $2M | $45.0K | $35.0K | $288.1K | $800.8K | · | · | · | · | · | |
| Other Non-op | $-212.0K | $-193.0K | $-287.0K | $-635.0K | $-252.0K | $-128.5K | $-227.3K | $-127.1K | $-10.1K | $4.5K | $-2M | $-1M | |
| Pretax Income | $183M | $126M | $-28M | $-66M | · | · | · | · | · | $-20M | $-18M | $-17M | |
| Income Tax | $36M | $-72M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-551.7K | |
| Net Income | $147M | $198M | $-28M | $-66M | $-72M | $-76M | $-48M | $-66M | $-44M | $-20M | $-18M | $-17M | |
| EPS (Basic) | $0.62 | $0.85 | $-0.13 | $-0.33 | $-0.51 | $-0.88 | · | · | · | · | · | · | |
| EPS (Diluted) | $0.60 | $0.81 | $-0.13 | $-0.33 | $-0.51 | $-0.88 | · | · | · | · | · | · | |
| Shares (Basic) | 238,299,024 | 233,084,236 | 223,977,315 | 197,874,895 | 139,578,538 | 86,145,052 | · | · | · | · | · | · | |
| Shares (Diluted) | 244,904,640 | 243,342,466 | 223,977,315 | 197,874,895 | 139,578,538 | 86,145,052 | · | · | · | · | · | · | |
| EBITDA | $199M | $147M | $29M | $-33M | $-54M | $-62M | $-39M | $-58M | $-38M | $-17M | $-15M | $-16M |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $88M | $103M | $51M | $87M | $51M | $56M | $27M | $27M | $43M | $10M | $10M | $17M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $0 | $5M | $6M | $5M | |
| Receivables | $158M | $50M | $27M | $16M | $29M | $13M | $3M | $1M | $4M | $1M | $924.5K | $384.0K | |
| Inventory | $206M | $170M | $173M | $163M | $125M | $82M | $53M | $19M | $13M | $5M | $3M | $2M | |
| Prepaid Expense | $7M | $8M | $5M | $5M | $4M | $3M | $3M | $2M | $1M | $313.9K | $111.0K | $143.6K | |
| Current Assets | $467M | $331M | $257M | $270M | $209M | $154M | $86M | $45M | $62M | $22M | $21M | $24M | |
| PP&E (Net) | $65M | $55M | $54M | $58M | $51M | $42M | $32M | $30M | $30M | $2M | $2M | $3M | |
| PP&E (Gross) | $103M | $88M | $81M | $78M | $64M | $50M | $37M | $34M | $32M | $4M | $4M | $4M | |
| Accum. Depreciation | $38M | $34M | $27M | $19M | $13M | $9M | $6M | $3M | $1M | $2M | $2M | $1M | |
| Goodwill | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $0 | · | · | |
| Intangibles | $632.0K | $460.0K | $499.0K | $1M | $2M | $2M | $3M | $4M | $5M | $0 | · | · | |
| Total Assets | $624M | $489M | $329M | $348M | $276M | $208M | $127M | $89M | $108M | $24M | $24M | $27M | |
| Accounts Payable | $23M | $20M | $16M | $13M | $12M | $11M | $9M | $6M | $6M | $3M | $2M | $2M | |
| Accrued Liabilities | · | · | · | · | · | $8M | $4M | $4M | $3M | $2M | $2M | $2M | |
| Short-term Debt | · | · | · | · | · | · | · | $0 | $0 | $6M | $0 | · | |
| Current Liabilities | $70M | $56M | $50M | $39M | $30M | $20M | $14M | $10M | $9M | $11M | $4M | $4M | |
| Capital Leases | $7M | $9M | $10M | $11M | $7M | $4M | $1M | $119.1K | $0 | $19.7K | $36.3K | $51.4K | |
| Other Non-current Liabilities | $0 | $360.0K | $419.0K | $350.0K | $397.4K | $54.9K | $106.6K | $260.7K | $106.0K | $117.8K | $1M | $132.5K | |
| Total Liabilities | $147M | $140M | $194M | $196M | $135M | $119M | $101M | $69M | $68M | $28M | $23M | $21M | |
| Long-term Debt | $72M | $72M | · | · | · | · | $0 | $3M | $3M | $2M | · | · | |
| Total Debt | $72M | · | · | · | · | · | · | $0 | $0 | $6M | · | · | |
| Common Stock | $24.0K | $24.0K | $23.0K | $22.0K | $19.6K | $10.5K | $5.9K | $4.6K | $3.7K | $1.3K | $1.1K | $929 | |
| Paid-in Capital | $671M | $658M | $641M | $630M | $553M | $429M | $291M | $236M | $191M | $102M | $88M | $75M | |
| Retained Earnings | $-162M | $-309M | $-506M | $-478M | $-412M | $-340M | $-265M | $-216M | $-151M | $-107M | $-87M | $-69M | |
| Treasury Stock | $32M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $477M | $349M | $135M | $152M | $141M | $88M | $26M | $20M | $40M | $-4M | $821.0K | $6M | |
| Liabilities + Equity | $624M | $489M | $329M | $348M | $276M | $208M | $127M | $89M | $108M | $24M | $24M | $27M | |
| Shares Outstanding | 237,874,496 | 236,620,545 | 226,063,032 | 221,816,930 | 195,813,817 | 104,902,888 | 59,318,355 | 46,353,068 | 36,725,499 | 12,886,741 | 10,713,087 | 9,291,823 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $8M | $8M | $6M | $5M | $3M | $2M | $3M | $2M | $400.0K | $469.8K | $247.9K | |
| Stock-based Comp | $20M | $14M | $6M | $5M | $3M | $3M | $3M | $2M | $2M | $1M | $2M | $1M | |
| Deferred Tax | $11M | $-84M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $144.0K | $388.0K | $724.0K | $715.0K | $715.0K | $715.4K | $844.9K | $844.9K | $1M | $0 | · | · | |
| Other Non-cash | $-136M | $-16M | $23M | $-5M | $-49M | $-32M | $-33M | $-2M | $3M | $-473.5K | $370.7K | $611.9K | |
| Operating Cash Flow | $50M | $119M | $9M | $-60M | $-112M | $-102M | $-76M | $-63M | $-37M | $-18M | $-15M | $-15M | |
| CapEx | $23M | $8M | $5M | $14M | $14M | $13M | $4M | $2M | $3M | $73.4K | $26.1K | $2M | |
| Investing Cash Flow | $-22M | $-9M | $-5M | $-14M | $-14M | $-13M | $-4M | $-2M | $15M | $904.6K | $-2M | $-4M | |
| Debt Issued | · | · | · | · | · | $28M | $72M | $0 | $30M | $4M | · | · | |
| Net Debt Issued | · | · | · | · | · | $14M | $72M | $0 | $30M | · | · | · | |
| Stock Issued | · | $0 | $0 | $65M | $121M | $131M | $48M | $43M | $39M | $13M | $10M | $0 | |
| Stock Repurchased | $32M | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-32M | $0 | $0 | $65M | $121M | $131M | $48M | $43M | $39M | $14M | $10M | $0 | |
| Financing Cash Flow | $-44M | $-58M | $-39M | $109M | $121M | $144M | $80M | $43M | $61M | $17M | $10M | $10M | |
| Net Change in Cash | $-16M | $52M | $-35M | $35M | $-5M | $29M | $-2.7K | $-22M | $39M | $-526.1K | $-7M | $-9M | |
| Taxes Paid | $20M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $28M | $110M | $4M | $-73M | $-126M | $-115M | $-80M | $-65M | $-40M | $-18M | $-15M | $-17M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-21M | $-17M | $-18M |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 57.4% | 51.5% | 34.4% | 22.9% | 1.5% | · | · | -148.4% | -28.1% | 40.3% | 39.9% | 36.7% | |
| Operating Margin | 37.5% | 32.6% | 8.4% | -25.6% | -72.1% | -153.8% | -141.1% | -354.9% | -172.7% | -162.6% | -216.1% | -270.8% | |
| Net Margin | 28.8% | 46.4% | -10.9% | -42.8% | -88.5% | -179.4% | -164.5% | -387.1% | -192.3% | -183.1% | -250.4% | -284.2% | |
| Pretax Margin | 35.8% | 29.5% | · | · | · | · | · | · | · | -183.1% | -250.4% | -293.6% | |
| EBITDA Margin | 39.1% | 34.4% | 11.3% | -21.4% | -66.2% | -146.2% | -133.0% | -339.6% | -166.1% | -158.1% | -209.6% | -266.6% | |
| ROA | 26.4% | 45.0% | -8.3% | -20.3% | -27.8% | -38.1% | -47.0% | -67.3% | -66.5% | -82.3% | -70.8% | -56.8% | |
| ROE | 33.6% | 68.1% | -19.7% | -52.2% | -58.7% | -94.9% | -155.0% | -230.8% | -243.9% | 1073.4% | -526.2% | -153.5% | |
| ROIC | 28.0% | 62.6% | · | · | · | · | · | · | · | -1047.9% | -1889.7% | -258.1% |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.7 | 6.0 | 5.2 | 6.9 | 6.9 | 7.7 | 6.1 | 4.6 | 6.7 | 1.9 | 5.0 | 5.7 | |
| Quick Ratio | 3.5 | 2.8 | 1.6 | 2.6 | 2.6 | 3.5 | 2.2 | 2.5 | 5.0 | 1.5 | 4.2 | 5.3 | |
| Debt / Equity | 0.2 | · | · | · | · | · | · | 0.0 | 0.0 | -1.4 | · | · | |
| LT Debt / Equity | 0.1 | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | 0.9 | -2.0 | -4.5 | -5.4 | -4.6 | -10.9 | -12.0 | -7.7 | -8.4 | -12.5 |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 1.0 | 0.8 | 0.5 | 0.3 | 0.2 | 0.3 | 0.2 | 0.3 | 0.4 | 0.3 | 0.2 | |
| Inventory Turnover | 1.2 | 1.2 | 1.0 | 0.8 | 0.8 | 0.9 | 1.1 | 2.7 | 0.3 | 1.5 | 1.7 | 2.8 | |
| Receivables Turnover | 4.9 | 11.0 | 12.0 | 7.0 | 3.9 | 5.1 | 12.1 | 6.4 | 9.3 | 11.0 | 11.0 | 13.6 |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.01 | $1.48 | $0.60 | $0.69 | $0.72 | $0.84 | $0.44 | $0.43 | $1.10 | $-0.35 | $0.08 | $0.65 | |
| Revenue / Share | $2.08 | $1.75 | $1.15 | $0.78 | $0.58 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $0.21 | $0.49 | $0.04 | $-0.30 | $-0.81 | · | · | · | · | · | · | · | |
| Cash / Share | $0.37 | $0.44 | $0.23 | $0.39 | $0.26 | $0.53 | $0.45 | $0.49 | $1.17 | $0.77 | $0.97 | $1.85 | |
| EPS (TTM) | $0.60 | $0.81 | $-0.13 | $-0.33 | $-0.51 | $-0.88 | · | · | · | · | · | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 19.6% | 65.1% | 67.6% | 90.4% | 91.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 49.0% | 74.0% | 82.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 64.6% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -25.9% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -25.7% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $510M | $426M | $258M | $154M | $81M | $42M | $29M | $17M | $23M | $11M | $7M | $6M | |
| Net Income TTM | $147M | $198M | $-28M | $-66M | $-72M | $-76M | $-48M | $-66M | $-44M | $-20M | $-18M | $-17M | |
| Market Cap | $4.34B | $4.06B | $1.02B | $861M | $276M | $205M | $237M | $111M | $118M | $66M | $86M | $104M | |
| Enterprise Value | $4.32B | · | · | · | · | · | · | $88M | $75M | $57M | · | · | |
| P/E | 30.4 | 21.2 | -34.8 | -11.8 | -2.8 | -2.2 | · | · | · | · | · | · | |
| P/S | 8.5 | 9.5 | 4.0 | 5.6 | 3.4 | 4.8 | 8.1 | 6.5 | 5.2 | 6.2 | 12.0 | 17.5 | |
| P/B | 9.1 | 11.6 | 7.6 | 5.7 | 2.0 | 2.3 | 9.1 | 5.6 | 2.9 | -14.8 | 105.3 | 17.3 | |
| P / Tangible Book | 9.2 | 11.8 | 7.8 | 5.8 | 2.0 | 2.5 | · | · | · | · | · | · | |
| P / Cash Flow | 86.1 | 34.2 | 116.1 | -14.5 | -2.5 | -2.0 | -3.1 | -1.8 | -3.2 | -3.6 | -5.6 | -7.1 | |
| P / FCF | 156.0 | 36.7 | 253.6 | -11.7 | -2.2 | -1.8 | -3.0 | -1.7 | -3.0 | -3.6 | -5.6 | -6.1 | |
| EV / EBITDA | 21.7 | · | · | · | · | · | · | -1.5 | -2.0 | -3.4 | · | · | |
| EV / FCF | 155.4 | · | · | · | · | · | · | -1.4 | -1.9 | -3.1 | · | · | |
| EV / Revenue | 8.5 | · | · | · | · | · | · | 5.2 | 3.3 | 5.3 | · | · | |
| Earnings Yield | 3.3% | 4.7% | -2.9% | -8.5% | -36.2% | -45.1% | · | · | · | · | · | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $124M | $114M | $139M | $134M | $122M | $115M | $118M | $120M | $107M | $82M | $74M | $67M | $60M | $57M | $50M | $41M | |
| Cost of Revenue | $38M | $34M | $50M | $59M | $55M | $54M | $54M | $60M | $50M | $43M | $43M | $43M | $43M | $40M | $36M | $31M | |
| Gross Profit | $86M | $81M | $89M | $76M | $67M | $61M | $63M | $60M | $57M | $39M | $31M | $25M | $17M | $17M | $14M | $10M | |
| R&D Expense | $6M | $3M | $1M | $2M | $1M | $826.0K | $391.0K | $412.0K | $560.0K | $450.0K | $446.0K | $596.0K | $1M | $855.0K | $1M | $1M | |
| SG&A Expense | $27M | $27M | $24M | $22M | $22M | $24M | $23M | $19M | $17M | $16M | $16M | $15M | $14M | $15M | $14M | $13M | |
| Operating Expenses | $34M | $22M | $26M | $25M | $24M | $26M | $25M | $20M | $18M | $17M | $17M | $16M | $17M | $17M | $20M | $19M | |
| Operating Income | $52M | $58M | $63M | $51M | $43M | $35M | $38M | $40M | $39M | $22M | $14M | $9M | $-473.0K | $-813.0K | $-6M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $4M | · | $6M | $6M | $6M | · | $6M | |
| Interest Income | · | · | $487.0K | $376.0K | $400.0K | $608.0K | $598.0K | $666.0K | $449.0K | $384.0K | $614.0K | $423.0K | $414.0K | $166.0K | $2.4K | $7.2K | |
| Other Non-op | $-22.0K | $-140.0K | $-19.0K | $-21.0K | $-108.0K | $-64.0K | $-86.0K | $-56.0K | $-16.0K | $-35.0K | $-102.0K | $-145.0K | $-13.0K | $-27.0K | $-439.1K | $-9.6K | |
| Pretax Income | $50M | $57M | $62M | $48M | $40M | $33M | $35M | $37M | $36M | $18M | $-18M | $3M | $-6M | $-7M | · | · | |
| Income Tax | $12M | $12M | $12M | $11M | $6M | $7M | $-77M | $840.0K | $4M | $595.0K | $0 | $0 | $0 | $0 | · | · | |
| Net Income | $38M | $45M | $49M | $36M | $34M | $27M | $112M | $36M | $32M | $18M | $-18M | $3M | $-6M | $-7M | $-12M | $-15M | |
| EPS (Basic) | $0.17 | $0.19 | $0.22 | $0.15 | $0.14 | $0.11 | $0.48 | $0.15 | $0.14 | $0.08 | $-0.08 | $0.01 | $-0.03 | $-0.03 | $-0.05 | $-0.08 | |
| EPS (Diluted) | $0.16 | $0.19 | $0.20 | $0.15 | $0.14 | $0.11 | $0.45 | $0.15 | $0.13 | $0.08 | $-0.08 | $0.01 | $-0.03 | $-0.03 | $-0.05 | $-0.08 | |
| Shares (Basic) | 228,232,503 | 236,072,751 | · | 238,602,978 | 241,490,715 | 237,775,476 | · | 234,571,376 | 232,417,645 | 228,874,847 | · | 225,276,980 | 222,683,393 | 221,921,750 | · | 196,383,935 | |
| Shares (Diluted) | 230,337,048 | 239,955,762 | · | 244,664,263 | 248,608,460 | 244,676,350 | · | 244,804,065 | 242,167,072 | 236,414,374 | · | 233,761,262 | 222,683,393 | 221,921,750 | · | 196,383,935 | |
| EBITDA | $54M | $60M | · | $53M | $45M | $37M | · | $42M | $41M | $24M | · | $11M | $1M | $1M | · | $-8M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $136M | $138M | $88M | $61M | $90M | $72M | $103M | $87M | $88M | $45M | · | $74M | $63M | $69M | · | $35M | |
| Receivables | $138M | $136M | $158M | $138M | $110M | $99M | $50M | $50M | $30M | $50M | · | $31M | $37M | $27M | · | $21M | |
| Inventory | $239M | $222M | $206M | $197M | $191M | $172M | $170M | $172M | $180M | $178M | · | $163M | $162M | $164M | · | $163M | |
| Prepaid Expense | $15M | $15M | $7M | $7M | $8M | $9M | $8M | $10M | $6M | $4M | · | $5M | $5M | $4M | · | $5M | |
| Current Assets | $528M | $511M | $467M | $403M | $400M | $352M | $331M | $318M | $304M | $276M | · | $274M | $266M | $264M | · | $224M | |
| PP&E (Net) | $67M | $65M | $65M | $70M | $58M | $58M | $55M | $54M | $54M | $55M | · | $55M | $56M | $57M | · | $57M | |
| PP&E (Gross) | $108M | $105M | $103M | · | $95M | $93M | $88M | $86M | $85M | $84M | · | $80M | $80M | $79M | · | $75M | |
| Accum. Depreciation | $42M | $40M | $38M | · | $38M | $35M | $34M | $32M | $31M | $29M | · | $25M | $23M | $21M | · | $18M | |
| Goodwill | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | |
| Intangibles | $575.0K | $630.0K | $632.0K | $491.0K | $527.0K | $452.0K | $460.0K | $485.0K | $479.0K | $321.0K | · | $476.9K | $655.7K | $834.6K | · | $1M | |
| Total Assets | $684M | $665M | $624M | $569M | $558M | $511M | $489M | $391M | $376M | $351M | $329M | $349M | $343M | $341M | $348M | $301M | |
| Accounts Payable | $32M | $21M | $23M | $24M | $30M | $21M | $20M | $16M | $14M | $17M | · | $11M | $12M | $13M | · | $25M | |
| Current Liabilities | $76M | $74M | $70M | $56M | $75M | $53M | $56M | $45M | $44M | $53M | · | $42M | $42M | $37M | · | $44M | |
| Capital Leases | $6M | $6M | $7M | $9M | $9M | $8M | $9M | $9M | $9M | $9M | · | $10M | $10M | $10M | · | $11M | |
| Other Non-current Liabilities | · | · | $0 | $90.0K | $2.0K | $2.0K | $360.0K | $375.0K | $390.0K | $405.0K | · | $434.6K | $449.5K | $338.7K | · | $362.2K | |
| Total Liabilities | $276M | $275M | $147M | $138M | $160M | $137M | $140M | $159M | $188M | $197M | · | $198M | $196M | $195M | · | $200M | |
| Long-term Debt | $197M | $197M | $72M | $72M | · | · | $72M | · | · | · | · | · | · | · | · | · | |
| Total Debt | $197M | $197M | · | $72M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $24.0K | $24.0K | $24.0K | $24.0K | $24.0K | $24.0K | $24.0K | $24.0K | $23.0K | $23.0K | · | $22.6K | $22.5K | $22.2K | · | $19.7K | |
| Paid-in Capital | $675M | $650M | $671M | $665M | $661M | $655M | $658M | $652M | $645M | $642M | · | $640M | $638M | $630M | · | $566M | |
| Retained Earnings | $-79M | $-116M | $-162M | $-211M | $-247M | $-282M | $-309M | $-420M | $-456M | $-488M | · | $-489M | $-491M | $-485M | · | $-466M | |
| Treasury Stock | $188M | $143M | $32M | $23M | $15M | · | $0 | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $408M | $390M | $477M | $431M | $398M | $373M | $349M | $232M | $188M | $154M | $135M | $151M | $147M | $146M | $152M | $100M | |
| Liabilities + Equity | $684M | $665M | $624M | $569M | $558M | $511M | $489M | $391M | $376M | $351M | · | $349M | $343M | $341M | · | $301M | |
| Shares Outstanding | 225,355,228 | 232,288,977 | 237,874,496 | 238,332,393 | 238,567,308 | 238,532,252 | 236,620,545 | 236,378,607 | 233,026,736 | 231,769,765 | · | 225,958,084 | 224,526,748 | 222,262,588 | · | 196,776,871 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Stock-based Comp | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Deferred Tax | $3.0K | $3M | $1M | $5M | $2M | $3M | $-84M | $0 | $0 | $0 | · | · | · | · | · | · | |
| Amort. of Intangibles | $55.0K | $55.0K | $49.0K | $38.0K | $32.0K | $25.0K | $25.0K | $28.0K | $142.0K | $193.0K | $187.0K | $179.0K | $179.0K | $179.0K | $178.5K | $178.8K | |
| Other Non-cash | · | $2M | · | · | · | $-57M | · | · | · | $-24M | · | · | · | $-11M | · | · | |
| Operating Cash Flow | $30M | $58M | $36M | $13M | $21M | $-20M | $50M | $25M | $46M | $-2M | $18M | $12M | $-6M | $-15M | $-7M | $-13M | |
| CapEx | $2M | $3M | $1M | $14M | $2M | $5M | $3M | $1M | $2M | $2M | $1M | $756.8K | $872.4K | $2M | $4M | $3M | |
| Investing Cash Flow | $-2M | $2M | $-276.0K | $-14M | $-3M | $-5M | $-3M | $-1M | $-2M | $-2M | $-1M | $-756.8K | $-872.4K | $-2M | $-4M | $-3M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $65M | $0 | |
| Stock Repurchased | $25M | $130M | $9M | $23M | $0 | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-130M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-29M | $-10M | $-9M | $-28M | $48.0K | $-7M | $-31M | $-25M | $-362.0K | $-1M | $-39M | $416.4K | $240.5K | $-650.0K | $63M | $-843.8K | |
| Net Change in Cash | $-2M | $51M | $26M | $-29M | $19M | $-32M | $16M | $-2M | $43M | $-6M | $-23M | $12M | $-7M | $-17M | $52M | $-18M | |
| Free Cash Flow | · | $56M | · | · | · | $-24M | · | · | · | $-5M | · | · | · | $-17M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-8M | · | · | · | · | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.4% | 70.5% | · | 56.3% | 55.1% | 53.2% | · | 49.8% | 53.6% | 47.8% | · | 36.6% | 27.8% | 29.0% | · | 23.5% | |
| Operating Margin | 42.2% | 50.9% | · | 38.0% | 35.1% | 30.4% | · | 33.1% | 36.6% | 26.7% | · | 12.9% | -0.79% | -1.4% | · | -22.7% | |
| Net Margin | 30.4% | 39.6% | · | 27.1% | 28.1% | 23.4% | · | 30.0% | 29.9% | 21.8% | · | 3.8% | -10.6% | -11.9% | · | -36.3% | |
| Pretax Margin | 40.4% | 49.9% | · | 35.4% | 32.9% | 29.1% | · | 30.7% | 33.5% | 22.5% | · | · | · | · | · | · | |
| EBITDA Margin | 43.5% | 52.5% | · | 39.5% | 36.7% | 32.0% | · | 34.7% | 38.3% | 29.0% | · | 15.7% | 2.4% | 1.9% | · | -18.5% | |
| ROA | 6.1% | 7.7% | · | 7.6% | 7.3% | 6.2% | · | 9.7% | 8.9% | 5.1% | · | 0.79% | -2.0% | -2.1% | · | -5.5% | |
| ROE | 9.4% | 11.9% | · | 11.0% | 11.7% | 10.2% | · | 18.7% | 19.1% | 11.9% | · | 2.0% | -4.9% | -5.0% | · | -14.7% | |
| ROIC | 6.5% | 7.9% | · | 7.8% | 9.2% | 7.5% | · | 16.7% | 18.6% | 13.7% | · | · | · | · | · | · |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | 7.0 | · | 7.1 | 5.3 | 6.6 | · | 7.1 | 6.9 | 5.2 | · | 6.5 | 6.3 | 7.2 | · | 5.0 | |
| Quick Ratio | 3.6 | 3.7 | · | 3.5 | 2.7 | 3.2 | · | 3.0 | 2.7 | 1.8 | · | 2.5 | 2.4 | 2.6 | · | 1.3 | |
| Debt / Equity | 0.5 | 0.5 | · | 0.2 | · | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.5 | 0.5 | · | 0.2 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 5.8 | · | 1.4 | -0.1 | -0.1 | · | -1.7 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | |
| Receivables Turnover | 1.0 | 1.0 | · | 1.4 | 1.7 | 1.5 | · | 2.9 | 3.2 | 2.2 | · | 2.6 | 2.2 | 2.2 | · | 2.0 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.81 | $1.68 | · | $1.81 | $1.67 | $1.57 | · | $0.98 | $0.81 | $0.66 | · | $0.67 | $0.65 | $0.66 | · | $0.51 | |
| Revenue / Share | $0.54 | $0.48 | · | $0.55 | $0.49 | $0.47 | · | $0.49 | $0.44 | $0.35 | · | $0.29 | $0.27 | $0.26 | · | $0.21 | |
| Cash Flow / Share | · | $0.24 | · | · | · | $-0.08 | · | · | · | $-0.01 | · | · | · | $-0.07 | · | · | |
| Cash / Share | $0.60 | $0.59 | · | $0.26 | $0.38 | $0.30 | · | $0.37 | $0.38 | $0.20 | · | $0.33 | $0.28 | $0.31 | · | $0.18 | |
| EPS (TTM) | $0.70 | $0.68 | · | $0.85 | $0.85 | $0.84 | · | $0.28 | $0.14 | $-0.02 | · | $-0.10 | $-0.19 | $-0.23 | · | $-0.35 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $512M | $510M | · | $489M | $474M | $459M | · | $383M | $330M | $283M | · | $234M | $208M | $182M | · | $130M | |
| Net Income TTM | $169M | $165M | · | $209M | $209M | $207M | · | $68M | $35M | $-4M | · | $-23M | $-40M | $-48M | · | $-70M | |
| Market Cap | $1.89B | $2.09B | · | $3.49B | $4.34B | $4.73B | · | $4.73B | $2.61B | $1.53B | · | $809M | $829M | $736M | · | $478M | |
| Enterprise Value | $1.95B | $2.15B | · | $3.50B | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | 12.0 | 13.2 | · | 17.2 | 21.4 | 23.6 | · | 71.4 | 79.9 | -330.0 | · | -35.8 | -19.4 | -14.4 | · | -6.9 | |
| P/S | 3.7 | 4.1 | · | 7.2 | 9.2 | 10.3 | · | 12.3 | 7.9 | 5.4 | · | 3.5 | 4.0 | 4.0 | · | 3.7 | |
| P/B | 4.6 | 5.4 | · | 8.1 | 10.9 | 12.7 | · | 20.4 | 13.8 | 10.0 | · | 5.3 | 5.6 | 5.1 | · | 4.8 | |
| P / Tangible Book | 4.7 | 5.4 | · | 8.2 | 11.0 | 12.8 | · | 20.7 | 14.1 | 10.2 | · | 5.5 | 5.8 | 5.2 | · | 5.0 | |
| P / Cash Flow | · | 35.9 | · | · | · | -240.5 | · | · | · | -689.7 | · | · | · | -50.0 | · | · | |
| EV / Revenue | 3.8 | 4.2 | · | 7.2 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 8.4% | 7.5% | · | 5.8% | 4.7% | 4.2% | · | 1.4% | 1.2% | -0.30% | · | -2.8% | -5.1% | -7.0% | · | -14.4% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|
| 收入 | $510M | · | · | $426M | · |
| 毛利率 % | 57.4% | · | · | 51.5% | · |
| 营业利润率 % | 37.5% | · | · | 32.6% | · |
| 净收入 | $147M | · | · | $198M | · |
| 稀释后每股收益 (EPS) | $0.60 | · | · | $0.81 | · |
| 指标 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.2 | · | · | · | · |
| 流动比率 | 6.7 | · | · | 6.0 | · |
| 速动比率 | 3.5 | · | · | 2.8 | · |
| 指标 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|
| 自由现金流 | $28M | · | · | $110M | · |
机构持有人 (13F) 361 家申报者 · $2.1B 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
361
持有价值
$2.1B
新仓位
53
已退出持仓
82
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 53 (-23 与上一季度对比) | 82 (+21 与上一季度对比) | 90 (-48 与上一季度对比) | 151 (+41 与上一季度对比) | -9.3M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| VANGUARD GROUP INC | $380389162 | 20854669 | 18.30% | 股份 |
| BlackRock, Inc. | $321037075 | 38355684 | 15.44% | 股份 |
| STATE STREET CORP | $143261104 | 17116022 | 6.89% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $84568881 | 10103809 | 4.07% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $84440661 | 10088490 | 4.06% | 股份 |
| Rubric Capital Management LP | $78170895 | 9339414 | 3.76% | 股份 |
| Capital Research Global Investors | $73290850 | 8756374 | 3.53% | 股份 |
| FIRST TRUST ADVISORS LP | $65272197 | 7798351 | 3.14% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $50731358 | 6059984 | 2.44% | 股份 |
| Caligan Partners LP | $47918309 | 5725007 | 2.31% | 股份 |
| D. E. Shaw & Co., Inc. | $44148376 | 5274597 | 2.12% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $30183960 | 3606208 | 1.45% | 股份 |
| GOLDMAN SACHS GROUP INC | $29408690 | 3513583 | 1.41% | 股份 |
| B Group, Inc. | $27307477 | 3262542 | 1.31% | 股份 |
| Nuveen, LLC | $27289121 | 3260349 | 1.31% | 股份 |
| NORTHERN TRUST CORP | $20221678 | 2415971 | 0.97% | 股份 |
| Nantahala Capital Management, LLC | $19753141 | 2359993 | 0.95% | 股份 |
| MORGAN STANLEY | $18961760 | 2265443 | 0.91% | 股份 |
| Ranger Investment Management, L.P. | $17706040 | 2115417 | 0.85% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $17515012 | 2092594 | 0.84% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $16906454 | 2019887 | 0.81% | 股份 |
| KENNEDY CAPITAL MANAGEMENT LLC | $14690622 | 1755152 | 0.71% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $13849111 | 1654613 | 0.67% | 股份 |
| Fundsmith LLP | $13806256 | 1649493 | 0.66% | 股份 |
| BANK OF AMERICA CORP /DE/ | $13790805 | 1647647 | 0.66% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $12769114 | 1525581 | 0.61% | 股份 |
| Life Cycle Investment Partners Ltd | $12747351 | 1522981 | 0.61% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $12172449 | 1454295 | 0.59% | 股份 |
| PRINCIPAL FINANCIAL GROUP INC | $11548114 | 1379703 | 0.56% | 股份 |
| CITADEL ADVISORS LLC | $11467494 | 1370071 | 0.55% | 股份 |
| Clearline Capital LP | $11171648 | 1334725 | 0.54% | 股份 |
| Qube Research & Technologies Ltd | $11019674 | 1316568 | 0.53% | 股份 |
| Bank of New York Mellon Corp | $10468003 | 1250658 | 0.50% | 股份 |
| National Philanthropic Trust | $10006302 | 1195496 | 0.48% | 股份 |
| BOOTHBAY FUND MANAGEMENT, LLC | $9848828 | 1176682 | 0.47% | 股份 |
| UBS Group AG | $9818286 | 1173033 | 0.47% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $9660888 | 1154228 | 0.46% | 股份 |
| FEDERATED HERMES, INC. | $8494019 | 1014817 | 0.41% | 股份 |
| Caption Management, LLC | $8370000 | 1000000 | 0.40% | 卖出期权 |
| DEUTSCHE BANK AG\ | $8174242 | 976612 | 0.39% | 股份 |
| Stonepine Capital Management, LLC | $7950000 | 650000 | 0.38% | 买入期权 |
| ROYAL BANK OF CANADA | $7368000 | 880330 | 0.35% | 股份 |
| Public Sector Pension Investment Board | $6664370 | 796221 | 0.32% | 股份 |
| ALGERT GLOBAL LLC | $6505072 | 777189 | 0.31% | 股份 |
| Stonepine Capital Management, LLC | $6193800 | 740000 | 0.30% | 股份 |
| Russell Investments Group, Ltd. | $6092357 | 727880 | 0.29% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5749537 | 686922 | 0.28% | 股份 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $5582790 | 667000 | 0.27% | 股份 |
| JANE STREET GROUP, LLC | $5541626 | 662082 | 0.27% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $5461676 | 652530 | 0.26% | 股份 |
激进投资者及 5%+ 股东 9 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Caligan Partners LP, David Johnson ×2 申报 | 2022年12月9日 | · | 初始申报 | 被动投资 | SEC |
| The Biotest Divestiture Trust, Eric Rosenbach ×2 申报 | 2019年6月7日 | · | 初始申报 | · | SEC |
| Biotest AG ×3 申报 | 2018年8月3日 | · | 初始申报 | · | SEC |
| Biotest Pharmaceuticals Corporation | 2018年5月21日 | · | 初始申报 | · | SEC |
| OR ×8 申报 | 2017年11月16日 | · | 初始申报 | · | SEC |
| Biomark Capital Fund IV LP (the “Fund”), Biomark Capital Fund IV GP LLC (the “General Partner”), David S. Wetherell (“Wetherell”) | 2017年1月30日 | · | 初始申报 | 被动投资 | SEC |
| Burrill Capital Fund IV, L.P. (the “Fund”), Burrill & Company (BCF IV GP), LLC (the “General Partner”), G. Steven Burrill (“Burrill”), Bryant Fong (“Fong”), Victor Hebert (“Hebert”), Douglas Lind (“Lind”), David Wetherell (“Wetherell”), Joshua Zelig (“Zelig”) ×2 申报 | 2013年10月28日 | · | 初始申报 | 被动投资 | SEC |
| 未披露的报告人 | 2006年9月15日 | · | 初始申报 | · | SEC |
| 未披露的报告人 | 2006年9月8日 | · | 初始申报 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 20 位内幕人士 · 8 位高管 · 12 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Adam S Grossman | President and CEO | 2026年3月16日 M | 2112777 | 0 | 10 | $-1743630 |
| Terry Kohler | CFO and Treasurer | 2026年7月16日 A | 143149 | 0 | 0 | $0 |
| Brad L. Tade | CFO and Treasurer | 2026年2月19日 F | 232940 | 0 | 0 | $0 |
| Brian Lenz | EVP, CFO | 2024年3月7日 F | 703002 | 0 | 0 | $0 |
| Kirk M Warshaw | CFO, Secretary | 2012年2月13日 D | 5208 | 0 | 0 | $0 |
| Arnold P Kling | President | 2012年2月13日 D | 8485 | 0 | 0 | $0 |
| Kaitlin M. Kestenberg-Messina | COO and SVP, Compliance | 2026年7月24日 F | 443061 | 0 | 1 | $-157800 |
| James Mond | EVP, CSO and CMO | 2021年2月25日 A | 137535 | 0 | 0 | $0 |
| Jerrold B Grossman | 董事 | 2026年5月27日 P | 520284 | 3 | 0 | $250874 |
| Lawrence P. Guiheen | 董事 | 2026年3月13日 M | 30000 | 0 | 0 | $0 |
| Steve Elms | 董事 | 2026年3月6日 P | 2045730 | 2 | 0 | $217420 |
| Eduardo Rene Salas | 董事 | 2026年2月9日 A | 21579 | 0 | 0 | $0 |
| Young Kwon | 董事 | 2026年2月9日 A | 263020 | 0 | 0 | $0 |
| Alison Cecily Finger | 董事 | 2026年2月9日 A | 45619 | 0 | 0 | $0 |
| Bryant Fong | 董事 | 2024年2月26日 A | 83941 | 0 | 0 | $0 |
| Martha J Demski | 董事 | 2023年3月6日 A | 56601 | 0 | 0 | $0 |
| Eric I Richman | 董事 | 2020年2月28日 A | 44030 | 0 | 0 | $0 |
| GOLDSTEIN DOV A MD | 董事 | 2020年2月28日 A | 7500 | 0 | 0 | $0 |
| Biotest Divestiture Trust | 10% 所有者 | 2019年6月6日 S | 4295580 | 0 | 0 | $0 |
| R & R INVESTMENTS VI LLC | 10% 所有者 | 2012年2月13日 D | 39340 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 46 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1.42% | 165305 NS | 2026年7月31日 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trus... | 1.21% | 215300 SH | 2026年10月1日 | 每日 |
| LABU · Direxion Shares ETF Trust | 0.45% | 264044 NS | 2026年7月31日 | N-PORT |
| CAFG · Pacer Funds Trust | 0.34% | 12285 NS | 2026年7月31日 | N-PORT |
| RZG · Invesco Exchange-Traded Fund Trust | 0.31% | 37244 SH | 2026年10月1日 | 每日 |
| VIOG · VANGUARD ADMIRAL FUNDS | 0.21% | 275878 SH | 2026年8月19日 | 每日 |
| IBB · iShares Trust | 0.16% | 1726703 SH | 2026年9月11日 | 每日 |
| QVMS · Invesco Exchange-Traded Fund Trus... | 0.15% | 34756 SH | 2026年10月1日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.15% | 15852 SH | 2026年10月1日 | 每日 |
| IWO · iShares Trust | 0.14% | 2176078 SH | 2026年9月11日 | 每日 |
| PWS · Pacer Funds Trust | 0.13% | 3607 NS | 2026年7月31日 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.11% | 247366 SH | 2026年8月19日 | 每日 |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.10% | 807920 SH | 2026年8月19日 | 每日 |
| BKSE · BNY Mellon ETF Trust | 0.08% | 8685 NS | 2026年7月31日 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.08% | 61860 NS | 2026年7月31日 | N-PORT |
| IWM · iShares Trust | 0.07% | 5882053 SH | 2026年9月11日 | 每日 |
| ISCG · iShares Trust | 0.07% | 72134 SH | 2026年9月11日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.06% | 1327333 SH | 2026年8月19日 | 每日 |
| JPSE · J.P. Morgan Exchange-Traded Fund ... | 0.05% | 32883 NS | 2026年7月31日 | N-PORT |
| EBIT · Harbor ETF Trust | 0.04% | 617 NS | 2026年7月31日 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trus... | 0.04% | 68652 SH | 2026年10月1日 | 每日 |
| VBK · VANGUARD INDEX FUNDS | 0.03% | 1448225 SH | 2026年8月19日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.03% | 664197 SH | 2026年8月19日 | 每日 |
| FHLC · FIDELITY COVINGTON TRUST | 0.03% | 104878 NS | 2026年7月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.03% | 464320 NS | 2026年7月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.02% | 2659600 SH | 2026年8月19日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.02% | 52857 SH | 2026年10月1日 | 每日 |
| WSML · iShares Trust | 0.02% | 13738 SH | 2026年9月11日 | 每日 |
| DXUV · Dimensional ETF Trust | 0.02% | 11553 NS | 2026年7月31日 | N-PORT |
| SMDX · Tidal Trust III | 0.01% | 1866 NS | 2026年7月31日 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0.01% | 2517984 SH | 2026年8月19日 | 每日 |
| IWV · iShares Trust | 0.00% | 66426 SH | 2026年9月3日 | 每日 |
| ITOT · iShares Trust | 0.00% | 309541 SH | 2026年9月11日 | 每日 |
| DFAC · Dimensional ETF Trust | 0.00% | 151191 NS | 2026年7月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 24505 NS | 2026年7月31日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 41956 NS | 2026年7月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 5446 NS | 2026年7月31日 | N-PORT |
| TILT · FlexShares Trust | 0.00% | 158 NS | 2026年7月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 7025272 SH | 2026年8月19日 | 每日 |
| VT · VANGUARD INTERNATIONAL EQUITY IND... | 0.00% | 192148 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 19272 SH | 2026年8月19日 | 每日 |
| ESGV · VANGUARD WORLD FUND | 0.00% | 50502 SH | 2026年8月19日 | 每日 |
| IJR · iShares Trust | · | 14131003 SH | 2026年9月10日 | 每日 |
| IJT · iShares Trust | · | 2197109 SH | 2026年9月9日 | 每日 |
| XJR · iShares Trust | · | 32072 SH | 2026年8月31日 | 每日 |
| ISCB · iShares Trust | · | 10075 SH | 2026年9月11日 | 每日 |
ADMA 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 11 位分析师
买入
中位数目标
$17.50
+80.0%
2 18.2%
强烈买入
7 63.6%
买入
2 18.2%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
4 位分析师 · 2026-09-28平均目标 $17.00 +74.9%
← 低于所有目标
当前价格 $9.72
最低$12.00
平均值$17.00
最高$21.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| IRON | $3.01B | -13.2 | · | · | -31.3% | · |
| NRIX | $1.80B | -5.8 | 53.9% | -314.9% | -53.6% | · |
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | · |
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | · |
| SLS | $577M | -15.1 | · | · | -55.4% | · |
| RXRX | $2.16B | -2.8 | 26.9% | -863.4% | -62.9% | · |
| VERA | · | -10.9 | · | · | -55.9% | · |
| MLYS | $2.96B | -15.8 | · | · | -32.2% | · |
| BCRX | $1.66B | 6.4 | 94.1% | 30.2% | -97.6% | · |
最新新闻 提及该公司的近期头条新闻
交易信号 近期买入/卖出信号，包含入场价和风险/回报比
目前没有公开信号 — 没有卡片被填写，这是诚实的。
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 5, 2026 申报